| 2001–2010 | 2011–2019 | p value |
---|---|---|---|
N transplants | 265 | 744 | Â |
LT etiology*†| |||
NASH | 27 (10.2%) | 221 (29.7%) |  < 0.001 |
HCV | 111 (41.9%) | 176 (23.7%) | |
HBV | 56 (21.1%) | 168 (22.6%) | |
Wilson's disease | 11 (4.2%) | 12 (1.6%) | |
PSC | 4 (1.5%) | 24 (3.2%) | |
AIH | 29 (10.9%) | 60 (8.1%) | |
SCH | 5 (1.9%) | 16 (2.2%) | |
Other | 22 (8.3%) | 67 (9.0%) | |
Age [Median (IQR)]*‡ | 50 (37–57) | 56 (47–63) |  < 0.001 |
Male†| 166 (62.6%) | 468 (62.9%) | 0.940 |
BMI [Median (IQR)]‡ | 26.0 (22.4–30.0) | 26.2 (22.9–30.6) | 0.299 |
BMI group [n (%)]†| |||
Underweight | 13 (4.9%) | 36 (4.8%) | 0.767 |
Normal weight | 97 (36.6%) | 269 (36.2%) | |
Pre-obesity | 81 (30.6%) | 227 (30.5%) | |
Obesity (class 1) | 47 (17.7%) | 147 (19.8%) | |
Obesity (class 2) | 15 (5.7%) | 45 (6.1%) | |
Obesity (class 3) | 12 (4.5%) | 20 (2.7%) | |
Waitlist time [Median days (IQR)]*‡ | 82 (21–206) | 43 (15–112) |  < 0.001 |
LT from living donor [n (%)]*†| 74 (27.9%) | 554 (74.5%) |  < 0.001 |
MELD score [Median (IQR)]*‡ | 19 (14–28) | 22 (17–25) | 0.001 |
HCC candidate [n (%)]*†| 57 (21.5%) | 225 (30.2%) | 0.007 |